These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7711116)

  • 41. Aminoglycoside drugs in clinical practice: an evidence-based approach.
    Leibovici L; Vidal L; Paul M
    J Antimicrob Chemother; 2009 Feb; 63(2):246-51. PubMed ID: 19022778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.
    Craig WA
    Clin Infect Dis; 1998 Jan; 26(1):1-10; quiz 11-2. PubMed ID: 9455502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Bacterial endocarditis: microbiological diagnosis].
    Rotter M
    Acta Med Austriaca; 1993; 20(4):105-7. PubMed ID: 8237279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal co-amoxiclav ratios for inhibiting Escherichia coli strains with different susceptibilities to the compounds.
    Gracia M; Ponte C; Soriano F
    Int J Antimicrob Agents; 2005 Apr; 25(4):352-3. PubMed ID: 15784320
    [No Abstract]   [Full Text] [Related]  

  • 45. [Aminoglycoside antibiotics].
    Tateyama M; Saito A
    Nihon Rinsho; 1990 Oct; 48(10):2196-9. PubMed ID: 2280464
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antibiotic therapy for severe gram-negative infections].
    Vildé JL; Leport C
    Rev Prat; 1983 Jan; 33(3):117-24. PubMed ID: 6844820
    [No Abstract]   [Full Text] [Related]  

  • 47. [Systemic antibiotics in the treatment of periodontitis].
    American Academy of Periodontology
    Ned Tijdschr Tandheelkd; 1997 Aug; 104(8):291-7; discussion 298-9. PubMed ID: 11924413
    [No Abstract]   [Full Text] [Related]  

  • 48. Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.
    Pea F; Poz D; Viale P; Pavan F; Furlanut M
    J Antimicrob Chemother; 2006 Aug; 58(2):380-6. PubMed ID: 16735422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of the pharmacokinetic and pharmacodynamic characteristics of beta-lactam/beta-lactamase inhibitor combination antibiotics in premature infants.
    Rubino CM; Gal P; Ransom JL
    Pediatr Infect Dis J; 1998 Dec; 17(12):1200-10. PubMed ID: 9877383
    [No Abstract]   [Full Text] [Related]  

  • 50. Editorial commentary: Are blood concentrations enough for establishing pharmacokinetic/pharmacodynamic relationships?
    Craig WA
    Clin Infect Dis; 2014 Apr; 58(8):1084-5. PubMed ID: 24470275
    [No Abstract]   [Full Text] [Related]  

  • 51. [Drug therapy of respiratory tract infections in diabetes mellitus].
    Sato A; Tamura R; Okano A
    Nihon Rinsho; 1990 Oct; 48(10):2319-25. PubMed ID: 2280478
    [No Abstract]   [Full Text] [Related]  

  • 52. [Basis of quinolone antibiotics].
    Mitsuyama J
    Nihon Yakurigaku Zasshi; 2007 Oct; 130(4):287-93. PubMed ID: 17938514
    [No Abstract]   [Full Text] [Related]  

  • 53. Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.
    Landersdorfer CB; Bulitta JB; Kinzig M; Holzgrabe U; Sörgel F
    Clin Pharmacokinet; 2009; 48(2):89-124. PubMed ID: 19271782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.
    McKinnon PS; Davis SL
    Eur J Clin Microbiol Infect Dis; 2004 Apr; 23(4):271-88. PubMed ID: 15015030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Toward a reasonable prescription of antibiotic combinations].
    El Kabbadj M
    Maghrib Tibbi; 1981 Dec; 3(4):751-5. PubMed ID: 7348280
    [No Abstract]   [Full Text] [Related]  

  • 56. [Efficient antibiotic therapy].
    Milevskaia IuL
    Feldsher Akush; 1983 Dec; 48(12):30-3. PubMed ID: 6559698
    [No Abstract]   [Full Text] [Related]  

  • 57. [Recent progress in antimicrobial agents].
    Shimada K
    Nihon Naika Gakkai Zasshi; 1988 Oct; 77(10):1519-23. PubMed ID: 2854150
    [No Abstract]   [Full Text] [Related]  

  • 58. Meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides.
    Gilbert DN
    Clin Infect Dis; 1997 May; 24(5):816-9. PubMed ID: 9142774
    [No Abstract]   [Full Text] [Related]  

  • 59. Nursing update: aminoglycosides.
    Nursing; 1983 Feb; 13(2):83-4. PubMed ID: 6549799
    [No Abstract]   [Full Text] [Related]  

  • 60. Ozenoxacin: a review of absorption, dermal exposure and toxicity, tolerability and safety studies.
    Gropper S
    Future Microbiol; 2014; 9(8 Suppl):S1-2. PubMed ID: 25209518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.